#161909

Tera-2 Cell Line

Cat. #161909

Tera-2 Cell Line

Cat. #: 161909

Availability: 8-10 weeks

Organism: Human

Tissue: Lung

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jorgen Fogh

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Tera-2 Cell Line
  • Cancer: Carcinoma
  • Organism: Human
  • Gender: Male
  • Tissue: Lung
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Description: Human Carcinoma Cell Line Derived from a Lung Metastatic Site.
  • Application: 3D cell culture; Cancer research
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type A; Rh+

Applications

  • Application: 3D cell culture; Cancer research

Handling

  • Growth medium: McCoy's 5a Medium Modified supplemented with 15% FBS
  • Temperature: 37° C
  • Atmosphere: 95% Air, 5% CO2
  • Shipping conditions: Dry Ice
  • Storage medium: Culture medium 95%; DMSO, 5%
  • Storage conditions: Vapor phase of liquid nitrogen. Storage at -70° C will result in loss of viability.
  • Subculture routine: Subcultures are prepared by scraping. Remove spent medium, add fresh, dislodge cells from the floor of the flask, aspirate to disperse and dispense into new flasks. Subculture about once a week. Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended Medium Renewal: 2 to 3 times per week
  • Str profiling: Amelogenin: X,Y;CSF1PO: 10,12;D13S317: 13;D16S539: 11,12,13;D5S818: 9,12;D7S820: 10,12;TH01: 9.3;TPOX: 8;vWA: 18,19;D3S1358: 16;D21S11: 30,31;D18S51: 14;Penta_E: 5,14;Penta_D: 12,13;D8S1179: 13,15;FGA: 23;D19S433: 14,15.2;D2S1338: 22,25

References

  • Fogh J et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.